Encompass Health Co. (NYSE:EHC) Shares Bought by Commerce Bank

Commerce Bank raised its stake in shares of Encompass Health Co. (NYSE:EHC) by 2.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,835 shares of the company’s stock after acquiring an additional 200 shares during the period. Commerce Bank’s holdings in Encompass Health were worth $757,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in EHC. Dimensional Fund Advisors LP raised its position in Encompass Health by 1.2% in the second quarter. Dimensional Fund Advisors LP now owns 1,819,345 shares of the company’s stock valued at $156,083,000 after purchasing an additional 22,311 shares during the period. Copeland Capital Management LLC grew its stake in shares of Encompass Health by 1.0% in the third quarter. Copeland Capital Management LLC now owns 1,284,550 shares of the company’s stock valued at $124,139,000 after buying an additional 12,433 shares in the last quarter. Thrivent Financial for Lutherans raised its holdings in shares of Encompass Health by 26.0% in the 3rd quarter. Thrivent Financial for Lutherans now owns 760,496 shares of the company’s stock valued at $73,494,000 after buying an additional 156,938 shares during the period. Magnetar Financial LLC lifted its stake in Encompass Health by 1,176.6% during the 2nd quarter. Magnetar Financial LLC now owns 744,836 shares of the company’s stock worth $63,899,000 after acquiring an additional 814,018 shares in the last quarter. Finally, Reinhart Partners LLC. boosted its holdings in Encompass Health by 2.4% during the 3rd quarter. Reinhart Partners LLC. now owns 673,040 shares of the company’s stock valued at $65,043,000 after acquiring an additional 15,550 shares during the period. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Stock Up 0.9 %

Shares of NYSE EHC opened at $102.00 on Tuesday. Encompass Health Co. has a 1 year low of $63.78 and a 1 year high of $104.55. The company has a market capitalization of $10.28 billion, a price-to-earnings ratio of 24.64, a price-to-earnings-growth ratio of 1.34 and a beta of 0.88. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. The business has a 50-day moving average of $97.28 and a two-hundred day moving average of $90.99.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.94 by $0.09. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. During the same period in the prior year, the company posted $0.86 earnings per share. The firm’s quarterly revenue was up 11.9% compared to the same quarter last year. On average, analysts forecast that Encompass Health Co. will post 4.29 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be given a $0.17 dividend. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $0.68 dividend on an annualized basis and a yield of 0.67%. Encompass Health’s dividend payout ratio (DPR) is presently 16.43%.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on EHC. Barclays increased their price target on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Royal Bank of Canada raised their price target on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Truist Financial reaffirmed a “buy” rating and set a $116.00 price objective (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. UBS Group lifted their target price on Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, September 25th. Finally, Stephens reaffirmed an “overweight” rating and issued a $105.00 price target on shares of Encompass Health in a research report on Tuesday, August 6th. Nine analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, Encompass Health has a consensus rating of “Buy” and an average price target of $107.11.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.